Prestige Consumer Healthcare Inc. (PBH)

NYSE: PBH · USD

$47.9

+0.47 (+1.0%)· Recorded snapshot

Market cap	2.3B
Revenue (ttm)	1.1B
Net income (ttm)	172M
EPS (ttm)	$3.58
Shares out	47.4M
P/E (trailing)	13.4x
P/E (forward)	10.1x
Volume	400,047
Beta	0.34

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1B
Net income (ttm): 172M
EPS (ttm): $3.58
P/E (trailing): 13.4x
P/E (forward): 10.1x
Market cap: 2.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.1

P25 n/aP50 n/aP75 n/a

Trailing P/E13.4

P25 n/aP50 n/aP75 n/a

ROE9.1

P25 n/aP50 n/aP75 n/a

ROIC6.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PBH indicators

Market & fundamental data

Available fields

273

Groups with data

Currency

USD

Showing 273 of 273 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001295947
Company name	Prestige Consumer Healthcare Inc.
Country	United States
Country code	US
CUSIP number	74112D101
Earnings date	2026-11-05
Earnings time	bmo
Employees	890
Employees change	290
Employees growth	48.33%
Enterprise value	$4.2B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	1996
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2005-02-10
Is primary listing	Yes
Is SPAC	No
ISIN number	US74112D1019
Last 10-K release date	2026-05-14
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$47.86
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PBH
U.S. state	New York
Website	https://www.prestigebrands.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	11.37x
Average P/E ratio (10Y)	16.99x
Average P/E ratio (3Y)	16.66x
Average P/E ratio (5Y)	15.77x
Earnings yield	7.47%
EV/Earnings	24.61x
EV/EBIT	14.45x
EV/EBITDA	13.01x
EV/FCF	17.99x
EV/Sales	3.83x
FCF / EV yield	5.56%
FCF yield	10.44%
Forward EV/Sales	3.11x
Forward P/E	10.12x
Forward P/S	1.66x
Graham number	57.05064
Graham upside	19.85%
Industry forward P/E	13.59x
Industry P/E	175.96x
Lynch fair value	$17.88
Lynch upside	-62.45%
P/(FCF - SBC) ratio	10.06x
P/(OCF - SBC) ratio	9.46x
P/B ratio	1.17x
P/E ratio	13.39x
P/FCF ratio	9.58x
P/OCF ratio	9.04x
P/S ratio	2.04x
PEG ratio	1.26x
Price/EBITDA ratio	6.93x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26.52%
EBITDA margin	29.45%
Effective tax rate	26.57%
FCF margin	21.3%
Gross margin	54.77%
Operating margin	26.52%
Pretax margin	21.2%
Profit margin	15.57%
Profit per employee	$193,272
Profitable quarters	13
Profitable years	3
Revenue per employee	$1.2M
ROA	4.58%
ROA (5Y)	6.13%
ROCE	6.64%
ROE	9.12%
ROE (5Y)	8.91%
ROIC	6.36%
ROIC (5Y)	9.59%
SBC / revenue	1.01%
Tax / revenue	5.63%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-16.09%
EPS growth (Q)	-35.79%
EPS growth (QoQ)	-46.24%
EPS growth 10Y	10.72%
EPS growth 5Y	0.25%
EPS growth years	0
FCF growth	-12.13%
FCF growth (Q)	-14.19%
FCF growth (QoQ)	78.27%
FCF growth 3Y	3.65%
FCF growth 5Y	2.45%
Gross profit growth	-5.1%
Gross profit growth (Q)	-0.51%
Gross profit growth 3Y	-1.2%
Gross profit growth 5Y	0.88%
Net income growth	-19.24%
Net income growth (Q)	-38.53%
Net income growth (QoQ)	-45.9%
Net income growth 5Y	-0.76%
Net income growth years	0
OCF growth	-9.56%
OCF growth (Q)	-10.41%
OCF growth (QoQ)	65.23%
OCF growth 10Y	3.19%
OCF growth 3Y	4.34%
OCF growth 5Y	1.65%
Operating income growth	-16.03%
Operating income growth (Q)	-22.85%
Operating income growth 3Y	-5.39%
Operating income growth 5Y	-1.03%
Revenue growth	-1.36%
Revenue growth (Q)	6.48%
Revenue growth (QoQ)	-5.65%
Revenue growth 10Y	2.98%
Revenue growth 3Y	-0.75%
Revenue growth 5Y	2.36%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-14M
Depreciation and amortization	$32.4M
EBIT	$293M
EBITDA	$325.4M
EPS	$3.58
FCF per share	$4.97
Financing cash flow	$898.7M
Free cash flow	$235.4M
Free cash flow minus SBC	$224.2M
Gross profit	$605.2M
Income taxes	$62.2M
Investing cash flow	$-1.2B
Net borrowing	$1B
Net cash flow	$-50.4M
Net income	$172M
Operating cash flow minus SBC	$238.3M
Operating income	$293M
Revenue	$1.1B
Stock-based compensation	$11.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.76
Book value per share	$40.46
Debt / EBITDA	5.86
Debt / equity	1.08
Debt / FCF	8.78
Goodwill	$650.8M
Interest coverage	6.36
Long-term assets	$4.1B
Long-term liabilities	$2.5B
Net cash (debt)	$-2B
Net cash / market cap	-87.73%
Net debt / EBITDA	6.08
Net debt / equity	1.03
Net debt / FCF	8.41
Piotroski F-Score	4
Property, plant and equipment	$164.2M
Shareholders' equity	$1.9B
Tangible book value	$-2B
Tangible book value per share	$-41.74
Total assets	$4.6B
Total cash	$89.1M
Total debt	$2.1B
Total liabilities	$2.7B
WACC	3.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.28
Current assets	$496.8M
Current liabilities	$153.8M
Current ratio	3.23
Inventory turnover	2.91
Net working capital	$277.7M
Quick ratio	1.8
Working capital	$343M
Working capital turnover	3.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.62%
Dividend yield	0%
Shareholder yield	3.62%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	2.69%
10Y return CAGR	0.27%
10Y total return	2.69%
150-day SMA	$50.48
15Y price change	326.9%
15Y return CAGR	10.16%
15Y total return	326.9%
1D price change	0.99%
1M price change	2.49%
1M total return	2.49%
1W price change	-3.22%
1W total return	-3.22%
1Y price change	-23.46%
1Y return CAGR	-23.47%
1Y total return	-23.46%
20-day SMA	$47.92
200-day SMA	$54.25
20Y price change	311.1%
20Y return CAGR	7.32%
20Y total return	311.1%
3M price change	-5.22%
3M total return	-5.22%
3Y price change	-18.83%
3Y return CAGR	-6.72%
3Y total return	-18.83%
50-day SMA	$48.62
50-day SMA vs 200-day SMA	50under200
52-week high	$71.07
52-week high date	2026-02-24
52-week low	$42.62
52-week low date	2026-05-14
5Y price change	-18.34%
5Y return CAGR	-3.97%
5Y total return	-18.34%
6M price change	-18.06%
6M total return	-18.06%
All-time high	$90.04
All-time high date	2025-03-10
All-time low	$3.92
All-time low date	2009-03-12
Average true range (ATR)	$1.50
Average volume	528.6K
Beta (1Y)	0.5
Beta (2Y)	0.39
Beta (5Y)	0.34
Change from 52-week high	-32.66%
Change from 52-week low	12.3%
Change from all-time high	-46.95%
Change from all-time low	1,118.62%
Change from open	1.66%
Day's gap	-0.65%
Dollar volume	$19.1M
High price	$48.02
Low price	$47.08
Monthly RSI	37.63
Open price	$47.08
Position in 52-week range	82.98%
Premarket change	-1.05%
Premarket close	$47.39
Premarket price	$46.89
Previous close	$47.39
Price vs 150-day SMA	-5.19%
Price vs 20-day SMA	-0.13%
Price vs 200-day SMA	-11.77%
Price vs 50-day SMA	-1.56%
Relative volume	0.76
RSI	48.05
Sharpe ratio	-0.77
Sharpe ratio (3Y)	-0.25
Sharpe ratio (5Y)	-0.17
Sortino ratio	-0.83
Sortino ratio (3Y)	-0.15
Sortino ratio (5Y)	-0.03
Volume	400K
Weekly RSI	42.37
YTD price change	-22.56%
YTD total return	-22.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46.7M
Float percentage	98.57%
Shares change (QoQ)	-0.17%
Shares change (YoY)	-3.62%
Shares held by insiders	1.41%
Shares held by institutions	115.08%
Shares outstanding	47.4M
Short % of float	9.95%
Short % of shares	9.8%
Short ratio	7.7 days

Deeper analysis on PBH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this PBH report

Is a complete PBH research report available?

No complete published report is available for Prestige Consumer Healthcare Inc. (PBH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Prestige Consumer Healthcare Inc. (PBH)

Price

Financial snapshot

Fair-value bridge

Latest news · PBH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PBH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PBH

Frequently asked questions